Tian Zhao

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial

Tian Zhao, Charmaine Griffiths, Emma L Arbon et al. · BMJ Open · 2018 · 109 citations · Full text

Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil

Jacqueline B. McCrea, Sreeraj Macha, Adedayo Adedoyin et al. · The Journal of Clinical Pharmacology · 2019 · 82 citations

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

Matthew L. Rizk, Elizabeth G. Rhee, Patricia Jumes et al. · Antimicrobial Agents and Chemotherapy · 2018 · 76 citations · Full text

Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study

Tian Zhao, Muhammad Aetesam‐ur‐Rahman, Andrew P. Sage et al. · Cardiovascular Research · 2021 · 64 citations · Full text

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease

Tian Zhao, Rouchelle Sriranjan, Zewen Kelvin Tuong et al. · NEJM Evidence · 2021 · 59 citations · Full text

T-regulatory Cell, Regulatory T-cell Response, Immunology +22